Sagimet Biosciences Inc - Ordinary Shares - Class A
NASDAQ:SGMT 11:31:04 AM EDT
Sagimet Biosciences Inc - Ordinary Shares - Class A Stock, NASDAQ:SGMT
155 Bovet Road, Suite 303, San Mateo, California 94402
United States of America
Phone: +1.650.561.8600
Number of Employees: 10
Description
Sagimet Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics for the treatment of infectious diseases. Its lead drug candidate, denifanstat, is an oral, once-daily pill and selective fatty acid synthase (FASN) inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH). The company was founded by Urs F. Greber, Ari Helenius, and Lucas Pelkmans on December 19, 2006 and is headquartered in San Mateo, CA.